Digital Conference agenda

* All times shown in EST

10:00 am Chair’s opening remarks

CAR-T FOR AUTOIMMUNE DISEASE

10:10 am C AR T-Cells & Drug-Expressing CAR T-Cells for Autoimmune Disease

10:35 am The CABA Platform: Identifying, Evaluating and Prioritizing Autoimmune Indications for CAAR T Therapy

  • Arun Das Senior Director, New Product Planning & Business Development, Cabaletta Bio

11:00 am Approaches to CAR T Cell Therapy in Preclinical Models of lupus

  • Marko Radic Associate Professor, University of Tennessee Health Science Center

11:25 am Live Q&A with your Expert Speakers

  • Michael Singer Chief Scientific Officer, Cartesian Therapeutics
  • Arun Das Senior Director, New Product Planning & Business Development, Cabaletta Bio
  • Marko Radic Associate Professor, University of Tennessee Health Science Center

Synopsis

Use this opportunity to ask your expert speakers those burning questions
For full session details, download the Event Guide

11:40 am Virtual Speed Networking

12:40 pm Transcriptional Profiling & TCR Clonotypes to Gain Translational Insights for a Pre-Manufactured, Clinical Stage Allogenic T-Cell Immunotherapy

  • Blake Aftab Vice President, Preclinical & Translational Science, Atara Biotherapeutics

1:05 pm CAR-T Cells for Targeting Antigen Specific CD4+ T Cells in Autoimmunity

1:30 pm TCR-Treg Cell Therapies to Induce Immune Tolerance for Hemophilia A

1:55 pm Live Q&A with your Expert Speakers

  • Blake Aftab Vice President, Preclinical & Translational Science, Atara Biotherapeutics
  • Edward Rosloniec Professor, University of Tennessee Health Science Center
  • Yong Chan Kim Chief Executive Officer, TeraImmune, Inc.

Synopsis

Use this opportunity to ask your expert speakers those burning questions

For full session details, download the Event Guide

2:10 pm Virtual Speed Networking

CAR-T FOR INFECTIOUS DISEASE

3:10 pm Engineering Long-Term HIV-Specific Immunity through Chimeric Antigen Receptors & Stem Cells

  • Scott Kitchen Associate Professor of Medicine, Director, UCLA Humanized Mouse Core Laboratory, UCLA

3:35 pm Experience with Gene Edited CAR T Cells to Treat SHIV Infected Primates

  • Thor Wagner Assistant Professor of Pediatric Infectious Diseases, Seattle Children’s Hospital

4:00 pm CAR-T Cells Against Lytic Herpesvirus Infections: Epstein-Barr Virus and Cytomegalovirus

4:25 pm Cell Therapies for Invasive Fungal Infections

4:50 pm Live Q&A with your Expert Speakers

  • Scott Kitchen Associate Professor of Medicine, Director, UCLA Humanized Mouse Core Laboratory, UCLA
  • Thor Wagner Assistant Professor of Pediatric Infectious Diseases, Seattle Children’s Hospital
  • Renata Stripecke Professor & Head of Laboratory, Hannover Medical School
  • Kumar Pappanaicken Assistant Professor, MD Anderson Cancer Center

Synopsis

Use this opportunity to ask your expert speakers those burning questions

For full session details, download the Event Guide

5:10 pm Virtual Speed Networking

CAR-T TO ACHIEVE ANTI-INFLAMMATION

5:40 pm Engineered T Regulatory Cell Products to Treat Neurodegenerative Diseases

6:05 pm CAR-T for Cardiovascular Disease

  • Jonathan Epstein Executive Vice Dean & Chief Scientific Officer, William Wikoff Smith Professor of Medicine, University of Pennsylvania

6:30 pm Live Q&A with your Expert Speakers

  • Philip Ashton-Rickardt Senior Vice President, Immunology, AZTherapies
  • Jonathan Epstein Executive Vice Dean & Chief Scientific Officer, William Wikoff Smith Professor of Medicine, University of Pennsylvania

Synopsis

Use this opportunity to ask your expert speakers those burning questions

For full session details, download the Event Guide

6:40 pm Chair’s closing remarks